A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis

Nature·Aug 19

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers have developed a blood test that may be able to detect amyotrophic lateral sclerosis (ALS) earlier and more accurately. The test, which uses machine learning and proteomics, has shown promise in identifying biomarkers for the disease, potentially years before symptoms appear. However, the specifics of the test's capabilities, such as the exact timeframe for detection, are not consistently reported across different sources.

Full coverage

ALS: Neutrophil degranulation markers rise before onset and track higher incident risk

Vera Health·Mar 8

Study Finds ALS Detectable Years Before Symptoms

Legal Reader·Oct 3

Machine learning-based proteomics profiling of ALS identifies downregulation of RPS29 that maintains protein homeostasis and STMN2 level

Nature·Aug 7

View original report at Nature ↗

Fetching the latest headlines…

A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis

Full coverage

Team Uses Machine Learning, Proteomics to Develop Accurate ALS Blood Test

Protein-based blood test detects early signs of ALS

Study points toward earlier and more accurate detection of ALS

Blood test could diagnose ALS years before symptoms appear: Study

Machine Learning Model Detects ALS Up to a Decade Before Symptoms Emerge

ALS: Neutrophil degranulation markers rise before onset and track higher incident risk

Study Finds ALS Detectable Years Before Symptoms

Machine learning-based proteomics profiling of ALS identifies downregulation of RPS29 that maintains protein homeostasis and STMN2 level